Intensity Therapeutics, Inc. announced it raised $500,000 in an initial filing from an offering of $5 Million
Intensity Therapeutics, Inc. announced it raised $500,000 in an initial filing from an offering of $5 Million
06/12/15, 7:57 PM
Location
shelton
Money raised
$500,000
Industry
manufacturing
Round Type
seed
Company Info
Location
shelton, connecticut, united states
Additional Info
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases.